| Enzo |
ALX-155-004-P001 |
ET A receptor antagonist [BQ-123] . sodium salt
|
1mg* |
|
|
| Enzo |
ALX-155-003-PC01 |
Endothelin 3 (human, rat, pig)
|
0.1mg* |
|
|
| Enzo |
ALX-155-004-P005 |
ET A receptor antagonist [BQ-123] . sodium salt
|
5mg* |
|
|
| Enzo |
ALX-155-007-PC05 |
ET B receptor antagonist [IRL-1038]
|
0.5mg* |
|
|
| Enzo |
ALX-155-007-P001 |
ET B receptor antagonist [IRL-1038]
|
1mg* |
|
|
| Enzo |
ALX-155-002-PC01 |
Endothelin 2 (human, pig, dog)
|
0.1mg* |
|
|
| Enzo |
ALX-155-003-PC05 |
Endothelin 3 (human, rat, pig)
|
0.5mg* |
|
|
| Enzo |
ALX-155-001-PC05 |
Endothelin 1 (human, mouse, rat, pig, bovine, dog)
|
0.5mg* |
|
|
| Enzo |
ALX-155-001-P001 |
Endothelin 1 (human, mouse, rat, pig, bovine, dog)
|
1mg* |
|
|
| Enzo |
ALX-153-055-G001 |
Carnosine
|
1g |
|
|
| Enzo |
ALX-153-064-M001 |
Caveolin 1 scaffolding domain peptide
|
1mg |
|
|
| Enzo |
ALX-153-064-M005 |
Caveolin 1 scaffolding domain peptide
|
5mg |
|
|
| Enzo |
ALX-153-066-C100 |
Blocking peptide for CCR3 (mouse) pAb (Prod. No. ALX-210-641)
|
100µg |
|
|
| Enzo |
ALX-155-001-PC01 |
Endothelin 1 (human, mouse, rat, pig, bovine, dog)
|
0.1mg* |
|
|
| Enzo |
ALX-152-001-PC05 |
Big Endothelin 1 (human) (1-38)
|
0.5mg* |
|
|
| Enzo |
ALX-152-003-PC01 |
Big Endothelin 1 (rat) (1-39)
|
0.1mg* |
|
|
| Enzo |
ALX-152-003-PC05 |
Big Endothelin 1 (rat) (1-39)
|
0.5mg* |
|
|
| Enzo |
ALX-152-006-M025 |
Bradykinin
|
25mg |
|
|
| Enzo |
ALX-152-006-M005 |
Bradykinin
|
5mg |
|
|
| Enzo |
ALX-152-028-1 |
Bax (58-75) (human) (cell permeable)
|
1Vial |
|
|
| Enzo |
ALX-152-031-M001 |
[Des-Arg1] Bradykinin
|
1mg |
|
|
| Enzo |
ALX-153-012-M001 |
Cyclin dependent kinase 2 inhibitor
|
1mg |
|
|
| Enzo |
ALX-153-003-M005 |
Casein kinase 2 substrate
|
5mg |
|
|
| Enzo |
ALX-153-003-M001 |
Casein kinase 2 substrate
|
1mg |
|
|
| Enzo |
ALX-151-045-C100 |
Blocking peptide for Adiponectin receptor 1 pAb (Prod. No. ALX-210-645)
|
100µg |
|
|
| Enzo |
ALX-152-001-PC01 |
Big Endothelin 1 (human) (1-38)
|
0.1mg* |
|
|
| Enzo |
ALX-152-001-P001 |
Big Endothelin 1 (human) (1-38)
|
1mg* |
|
|
| Enzo |
ALX-151-042-M005 |
Angiotensin IV
|
5mg |
|
|
| Enzo |
ALX-151-043-M005 |
Angiotensin III
|
5mg |
|
|
| Enzo |
ALX-151-041-M005 |
Angiotensin I/II (1-7)
|
5mg |
|
|
| Enzo |
ALX-151-039-M025 |
Angiotensin II
|
25mg |
|
|
| Enzo |
ALX-151-039-M005 |
Angiotensin II
|
5mg |
|
|
| Enzo |
ALX-151-037-M005 |
Angiotensin I
|
5mg |
|
|
| Enzo |
ALX-151-036-M001 |
Ac-muramyl-D-Ala-D-Glu-amide
|
1mg |
|
|
| Enzo |
ALX-151-035-M001 |
Ac-muramyl-Ala-D-Glu-amide
|
1mg |
|
|
| Enzo |
ALX-151-036-M005 |
Ac-muramyl-D-Ala-D-Glu-amide
|
5mg |
|
|
| Enzo |
ALX-151-030-MC05 |
Autocamtide 2 related inhibitory peptide (myristoylated)
|
0.5mg |
|
|
| Enzo |
ALX-151-035-M005 |
Ac-muramyl-Ala-D-Glu-amide
|
5mg |
|
|
| Enzo |
ALX-151-029-M005 |
Autocamtide 2 related inhibitory peptide
|
5mg |
|
|
| Enzo |
ALX-151-024-M001 |
H-Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg-OH
|
1mg |
|
|
| Enzo |
ALX-151-026-M001 |
N-Acetyl-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2
|
1mg |
|
|
| Enzo |
ALX-151-027-M001 |
N-Acetyl-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2
|
1mg |
|
|
| Enzo |
ALX-151-029-M001 |
Autocamtide 2 related inhibitory peptide
|
1mg |
|
|
| Enzo |
ALX-151-021-M001 |
H-Arg-Gly-Tyr-Ser-Leu-Gly-OH
|
1mg |
|
|
| Enzo |
ALX-151-020-M010 |
N-Acetyl-Asp-Glu-OH
|
10mg |
|
|
| Enzo |
ALX-151-020-M050 |
N-Acetyl-Asp-Glu-OH
|
50mg |
|
|
| Enzo |
ALX-151-018-MC05 |
cAMP dependent protein kinase inhibitor (5-24) amide
|
0.5mg |
|
|
| Enzo |
ALX-151-019-MC05 |
cAMP dependent protein kinase substrate
|
0.5mg |
|
|
| Enzo |
ALX-151-019-M001 |
cAMP dependent protein kinase substrate
|
1mg |
|
|
| Enzo |
ALX-151-016-MC05 |
cAMP dependent protein kinase inhibitor (5-22) amide
|
0.5mg |
|
|